Trials / Completed
CompletedNCT05254834
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,435 (actual)
- Sponsor
- Freenome Holdings Inc. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Freenome Test | Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled. |
Timeline
- Start date
- 2022-02-15
- Primary completion
- 2024-07-24
- Completion
- 2025-07-12
- First posted
- 2022-02-24
- Last updated
- 2025-08-22
Locations
68 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05254834. Inclusion in this directory is not an endorsement.